---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-033892"
form_type: "8-K"
ticker: null
cik: "0001603207"
company_name: "Notable Labs, Ltd."
filed_at: "2024-08-26T23:59:59+00:00"
generated_at: "2026-05-31T07:39:01.911186+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Notable Labs CEO Thomas Bock resigns; CSO Wagner named interim CEO

## Summary
- Thomas Bock resigned as CEO and director effective Aug 26, 2024; no disagreement with company.
- Joseph Wagner, CSO since 2020, appointed interim CEO; board initiates search for permanent CEO.
- Bock retained as consultant for 3 years: $21,875/month year 1, $10,937/month years 2-3; option extension to 10th anniversary.
- Wagner's annual base salary increased to $408k as of April 1, 2024; target bonus 30% of base.
- Company reaffirms plan to initiate volasertib Phase 2 program in coming months.

## SEC filing metadata
- accession: 0001493152-24-033892
- form_type: 8-K
- cik: 0001603207
- company_name: Notable Labs, Ltd.
- filed_at: 2024-08-26T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1603207/000149315224033892/0001493152-24-033892-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1603207/000149315224033892/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-033892
- JSON: https://secwatch.observer/filing/0001493152-24-033892.json
- Plain text: https://secwatch.observer/filing/0001493152-24-033892.txt

## Key facts
- Executive change
  Thomas A. Bock resigned as Chief Executive Officer at Notable Labs, Ltd..
  - Action: resigned
  - Role: Chief Executive Officer
  source text: On August 26, 2024, Dr. Thomas A. Bock resigned from his positions as Director and as Chief Executive Officer of Notable Labs, Ltd.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1603207/000149315224033892/0001493152-24-033892-index.htm
- Executive change
  Joseph Wagner was appointed as Chief Executive Officer at Notable Labs, Ltd..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: Simultaneously, on such date, Dr. Joseph Wagner, the Company’s Chief Scientific Officer, was also appointed as Chief Executive Officer on an interim basis while the Board of Directors completes a search for a new Chief Executive Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1603207/000149315224033892/0001493152-24-033892-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.